Cargando…
Anti-angiogenic therapies for the treatment of angiosarcoma: a clinical update
Angiosarcomas are rare aggressive endothelial tumours, and are associated with a poor prognosis. Due to their vascular nature, there is great interest in their response to anti-angiogenic agents. A number of small prospective studies have reported angiosarcoma response to vascular-targeted agents, i...
Autores principales: | Young, Robin J., Woll, Penella J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725516/ https://www.ncbi.nlm.nih.gov/pubmed/29250195 http://dx.doi.org/10.1007/s12254-017-0365-x |
Ejemplares similares
-
Anti-angiogenic therapies in brain metastases
por: Berghoff, Anna S., et al.
Publicado: (2018) -
Treatment of gastrointestinal stromal tumor: focus on imatinib mesylate
por: Din, Omar S, et al.
Publicado: (2008) -
Nephrotoxicity of Anti-Angiogenic Therapies
por: Van Wynsberghe, Margaux, et al.
Publicado: (2021) -
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
por: Liu, Zhen-Ling, et al.
Publicado: (2023) -
Aberrations in Angiogenic Signaling and MYC Amplifications are Distinguishing Features of Angiosarcoma
por: Kurisetty, Vittal, et al.
Publicado: (2013)